DOBIE KENNETH W has a total of 46 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are BENNETT C F, BENNETT FRANK C and MEIRAGTX UK II LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 33 | |
#2 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Climate change mitigation in goods production | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Sugars | |
#7 | Measuring microorganism processes | |
#8 | Animal care | |
#9 | Special acyclic compounds | |
#10 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Dobie Kenneth W | 46 |
#2 | Freier Susan M | 10 |
#3 | Mckay Robert | 4 |
#4 | Marcusson Eric G | 3 |
#5 | Zhang Hong | 2 |
#6 | Roach Mark P | 2 |
#7 | Pandey Sanjay K | 2 |
#8 | Ward Donna T | 2 |
#9 | Koller Erich | 2 |
#10 | Bhanot Sanjay | 2 |
Publication | Filing date | Title |
---|---|---|
US8101350B1 | Modulation of exportin 5 expression | |
US2007185044A1 | Modulation of ace2 expression | |
WO2005016947A2 | ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION | |
WO03105778A2 | Phosphatidylinositol-4-phosphate 5-kinase, type ii beta inhibitors for inhibiting angiogenesis |